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A Case of Propofol-Induced Delayed-Onset 
Refractory Myoclonic Seizures
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Hee Young Jo, M.D., Sang-Ho Kim, M.D.
Department of Neurology, College of Medicine, Dong-A University, Busan, Korea
Propofol, a GABA-mediated inhibitor of excitatory neurotransmitter, is a popular intravenous agent for general 
anesthesia and sedation. Its side effects reportedly include opisthotonus, seizures, and myoclonus, and are usually 
manageable. We present a patient who developed propofol-induced delayed-onset refractory myoclonic seizures 
that resisted antiepileptic drugs.
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Propofol (2,6-diisopropylphenol) has been widely 
used since 1980 for anesthesia, sedating patients in 
intensive care units, and treating intractable status 
epilepticus. Neuroexcitation is an uncommon but well- 
recognized side effect of propofol anesthesia and se-
dation. Side effects can occur during the induction 
of, maintenance of, or emergence from anesthesia. Some 
case reports have also described propofol-induced 
delayed-onset seizures.
1,2 However, these side effects 
seldom produce neurologic sequelae.
CASE REPORT
A 31-year-old woman visited her local hospital for 
an IVF (in vitro fertilization) procedure because of 
infertility. The patient had no previous medical history 
except for infertility and no history of epilepsy, drug 
abuse, or recent infection. She had undergone propofol 
anesthesia for an IVF procedure with no complications 
2 years previously. However, she lost consciousness 
and began to convulse 30 minutes after the end of 
this second experience of propofol anesthesia. Her 
seizure was stopped with a benzodiazepine injection 
and she recovered consciousness. A neurologic exa-
mination revealed a sedative mental state due to benzo-
diazepines, but other findings were unremarkable. On 
the next morning seizures developed again and were 
not controlled despite injecting benzodiazepines and 
phenytoin, so she was transferred to our hospital.
In our emergency room, her vital signs were stable 
except for a fever (39.4℃). The white cell count was 
21530/μl, the C-reactive protein level was increased 
to 10.84 mg/dl, and the troponin-I level was 0.59 
ng/ml, but the other laboratory findings were within 
normal limits. There was no evidence of infection in 
the chest X-ray, urinalysis, cerebrospinal fluid analysis, 
or gynecologic examination. Echocardiography and 
brain MRI findings were normal. On the following 
day her white cell count had decreased to 13800/μl, Jeon HW, et al. Propofol-Induced Delayed-Onset Refractory Myoclonic Seizures
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Figure 1. Example EEGs showing frequent generalized polyspike-and-wave complexes followed by 
rhythmic fast waves at 15 Hz. 
Figure 2. Example EEGs showing polyspike-and-wave complexes without rhythmic fast activity.
the troponin-I level was 0.12 ng/ml, and the fever had 
normalized.
An initial neurological examination showed deep- 
stupor mentality and long-lasting generalized myoclonic 
seizures followed by intermittent opisthotonus. Diazepam 
and lorazepam were injected immediately but did not 
control her seizures, and EEGs showed generalized 
polyspikes and waves followed by rhythmic fast waves 
at 15 Hz (Fig. 1). The generalized polyspike-and-wave 
complexes coincided with the occurrence of generalized 
myoclonic seizures, and the subsequent rhythmic fast 
waves coincided with brief opisthotonus. Valproic acid 
(1600 mg) was therefore injected over a 10-minute 
period, which stopped her opisthotonus but had no 
effect on her generalized myoclonic seizures. Continuous 
infusion of lorazepam at up to 9 mg/kg/hour for 48 
hours stopped the spontaneous myoclonic seizures, 
but myoclonic seizures could still be evoked by 
subtle stimulations such as light touch or sound, and 
ictal waves continued (Fig. 2). Therefore, Pentothal 
was infused continuously at 3 mg/kg/hour, which 
after 3 days decreased the frequency and severity of Journal of Clinical Neurology: Vol. 3, No. 3, 2007
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myoclonic seizures. This dosage of Pentothal infusion 
was maintained for 3 weeks because seizures recurred 
when the dosage was reduced. Her mentality recovered 
as the Pentothal dosage was reduced after adding 
valproic acid and topiramate, but the myoclonic seizures 
were aggravated when Pentothal was stopped. The 
addition of lamotrigine and phenobarbital allowed 
Pentothal infusion to be stopped, but myoclonic seizures 
could now be evoked by stimulation. Two months 
after admission, the frequency and severity of her 
myoclonic seizures were reduced sufficiently for the 
patient to perform the activities of daily living. 
DISCUSSION
Propofol is a rapid onset and short-acting intravenous 
anesthetic agent.
3 Since its introduction in 1980,
4 it 
has been widely used for anesthesia, sedating patients in 
intensive care units, and treating intractable status 
epilepticus.
3,4
Few side effects of propofol have been reported. 
Hypotension and dose-dependent breathing depression 
may occur during the induction of anesthesia, and a 
burning pain may occur in the region of injection. 
Neuroexcitation is an uncommon but well-recognized 
side effect of propofol anesthesia and sedation. Un-
responsiveness, myoclonus, transient opisthotonus, 
refractory dystonia, ataxia, seizures, and transient 
seizure-like phenomena, all occurring either with or 
without an altered mental status, have been described 
during the induction of, maintenance of, and emergence 
from propofol anesthesia and sedation. These comp-
lications occur most frequently at the induction and 
emergence states, so a rapid change in the propofol 
concentration in the brain may be crucial for the 
generation of seizures.
5
If patients are appropriately treated, most neurologic 
complications associated with propofol resolve sponta-
neously.
2,6 Additionally, abnormal EEG findings are 
rare after the neurologic complication has improved.
7
Several cases with delayed-onset seizures following 
propofol anesthesia have been reported, but most of 
the patients recovered with no neurological compli-
cations, and the duration of seizures was limited to 
no more than several days in all but one case (which 
lasted for 18 days).
8 Trotter and Serpell reported 
neurological sequelae that occurred in two children 
after the withdrawal of propofol infusion: twitching 
movements persisting for 18 days, and choreiform 
movements of the arms persisting for 9 days despite 
antiepileptic treatment.
9
The pathophysiological mechanisms underling the 
neuroexcitatory symptoms associated with propofol are 
unknown, but several possible mechanisms have been 
proposed, including dose-related effects on inhibitory 
and excitatory neurons, drug-induced decerebrate rigidity, 
strychnine-like effects on glycinergic and GABAergic 
pathways, uncoordinated neuronal oscillations because 
of GABA-mediated enhanced inhibitory transmission, 
a relaxant effect of central muscles at high tissue 
concentrations,
10 imbalance between cholinergic and 
dopaminergic activity at the level of basal ganglia, 
and epileptic dampening.
11 Propofol has a delayed 
terminal elimination half-life
12 that may reflect its slow 
return from poorly perfused peripheral compartments 
back into the central compartment. Hence, significant 
concentrations of propofol may persist for some time 
within the nervous system, producing effects that 
depend on the balance between inhibitory and excitatory 
neurons. However, additional studies are needed to 
determine the precise biochemical or biophysical origin 
of these excitatory phenomena associated with propofol 
use.
Our patient had no history of previous seizure events, 
and had not presented side effects when first exposed 
to propofol. However, her first seizure occurred during 
recovery from her second experience of propofol anes-
thesia, and this was easily controlled by a benzodia-
zepine injection. However, another delayed seizure 
occurred 1 day after this first seizure, and was aggra-
vated to status epilepticus. Although we had admini-
stered intensive antiepileptic treatment, her mentality 
did not improve and her seizures continued. Even 
though we had treated the patient with a combination 
therapy of antiepileptic agents for 2 months, her myo-
clonic seizures were not in complete remission when 
she was discharged from the hospital. To our knowledge, Jeon HW, et al. Propofol-Induced Delayed-Onset Refractory Myoclonic Seizures
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this is the first reported case of propofol-induced re-
fractory seizures in Korea. Our patient had delayed- 
onset refractory myoclonic seizures that resisted anti-
epileptic drugs and were documented by EEGs.
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